Logo image of CXX.DE

CLOROX COMPANY (CXX.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:CXX - US1890541097 - Common Stock

86.5 EUR
+2 (+2.37%)
Last: 1/2/2026, 7:00:00 PM
Fundamental Rating

4

CXX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 11 industry peers in the Household Products industry. CXX has a medium profitability rating, but doesn't score so well on its financial health evaluation. CXX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CXX was profitable.
In the past year CXX had a positive cash flow from operations.
In the past 5 years CXX has always been profitable.
In the past 5 years CXX always reported a positive cash flow from operatings.
CXX.DE Yearly Net Income VS EBIT VS OCF VS FCFCXX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 14.31%, CXX belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 21.90%, CXX belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CXX is in line with the industry average of 17.07%.
The last Return On Invested Capital (21.90%) for CXX is above the 3 year average (18.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROIC 21.9%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CXX.DE Yearly ROA, ROE, ROICCXX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200 250

1.3 Margins

Looking at the Profit Margin, with a value of 11.68%, CXX is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
In the last couple of years the Profit Margin of CXX has declined.
CXX has a Operating Margin (15.17%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CXX has declined.
CXX has a worse Gross Margin (44.28%) than 63.64% of its industry peers.
CXX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CXX.DE Yearly Profit, Operating, Gross MarginsCXX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CXX is creating value.
Compared to 1 year ago, CXX has less shares outstanding
CXX has less shares outstanding than it did 5 years ago.
CXX has a worse debt/assets ratio than last year.
CXX.DE Yearly Shares OutstandingCXX.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CXX.DE Yearly Total Debt VS Total AssetsCXX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

CXX has an Altman-Z score of 3.11. This indicates that CXX is financially healthy and has little risk of bankruptcy at the moment.
CXX's Altman-Z score of 3.11 is on the low side compared to the rest of the industry. CXX is outperformed by 63.64% of its industry peers.
The Debt to FCF ratio of CXX is 4.25, which is a neutral value as it means it would take CXX, 4.25 years of fcf income to pay off all of its debts.
CXX's Debt to FCF ratio of 4.25 is in line compared to the rest of the industry. CXX outperforms 45.45% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Altman-Z 3.11
ROIC/WACC2.85
WACC7.68%
CXX.DE Yearly LT Debt VS Equity VS FCFCXX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CXX has a Current Ratio of 0.76. This is a bad value and indicates that CXX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CXX (0.76) is comparable to the rest of the industry.
CXX has a Quick Ratio of 0.76. This is a bad value and indicates that CXX is not financially healthy enough and could expect problems in meeting its short term obligations.
CXX's Quick ratio of 0.50 is on the low side compared to the rest of the industry. CXX is outperformed by 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.5
CXX.DE Yearly Current Assets VS Current LiabilitesCXX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

CXX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.99%.
CXX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.01% yearly.
CXX shows a decrease in Revenue. In the last year, the revenue decreased by -9.35%.
The Revenue has been growing slightly by 1.11% on average over the past years.
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%

3.2 Future

Based on estimates for the next years, CXX will show a small growth in Earnings Per Share. The EPS will grow by 1.55% on average per year.
The Revenue is expected to grow by 1.20% on average over the next years.
EPS Next Y-22.5%
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%
EPS Next 5Y1.55%
Revenue Next Year-7.88%
Revenue Next 2Y-1.74%
Revenue Next 3Y-0.22%
Revenue Next 5Y1.2%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CXX.DE Yearly Revenue VS EstimatesCXX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
CXX.DE Yearly EPS VS EstimatesCXX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

CXX is valuated correctly with a Price/Earnings ratio of 15.12.
Compared to the rest of the industry, the Price/Earnings ratio of CXX indicates a somewhat cheap valuation: CXX is cheaper than 72.73% of the companies listed in the same industry.
CXX is valuated rather cheaply when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.89, CXX is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CXX indicates a rather cheap valuation: CXX is cheaper than 81.82% of the companies listed in the same industry.
CXX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.12
Fwd PE 14.89
CXX.DE Price Earnings VS Forward Price EarningsCXX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

63.64% of the companies in the same industry are more expensive than CXX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CXX is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.49
EV/EBITDA 11.79
CXX.DE Per share dataCXX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of CXX may justify a higher PE ratio.
A cheap valuation may be justified as CXX's earnings are expected to decrease with -2.23% in the coming years.
PEG (NY)N/A
PEG (5Y)14.92
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%

6

5. Dividend

5.1 Amount

CXX has a Yearly Dividend Yield of 4.92%, which is a nice return.
CXX's Dividend Yield is rather good when compared to the industry average which is at 3.00. CXX pays more dividend than 90.91% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, CXX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.92%

5.2 History

The dividend of CXX has a limited annual growth rate of 2.88%.
Dividend Growth(5Y)2.88%
Div Incr YearsN/A
Div Non Decr YearsN/A
CXX.DE Yearly Dividends per shareCXX.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2025 2026 1 2 3

5.3 Sustainability

76.11% of the earnings are spent on dividend by CXX. This is not a sustainable payout ratio.
CXX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP76.11%
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%
CXX.DE Yearly Income VS Free CF VS DividendCXX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CXX.DE Dividend Payout.CXX.DE Dividend Payout, showing the Payout Ratio.CXX.DE Dividend Payout.PayoutRetained Earnings

CLOROX COMPANY

FRA:CXX (1/2/2026, 7:00:00 PM)

86.5

+2 (+2.37%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)01-29 2026-01-29/amc
Inst Owners89.77%
Inst Owner ChangeN/A
Ins Owners0.4%
Ins Owner ChangeN/A
Market Cap10.55B
Revenue(TTM)6.77B
Net Income(TTM)791.00M
Analysts54.81
Price Target107.79 (24.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.92%
Yearly Dividend4.15
Dividend Growth(5Y)2.88%
DP76.11%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.83%
Min EPS beat(2)6.97%
Max EPS beat(2)28.7%
EPS beat(4)3
Avg EPS beat(4)9.13%
Min EPS beat(4)-8.29%
Max EPS beat(4)28.7%
EPS beat(8)7
Avg EPS beat(8)25.3%
EPS beat(12)11
Avg EPS beat(12)52.89%
EPS beat(16)13
Avg EPS beat(16)41.78%
Revenue beat(2)2
Avg Revenue beat(2)1.32%
Min Revenue beat(2)1.06%
Max Revenue beat(2)1.58%
Revenue beat(4)3
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)2.62%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)9
Avg Revenue beat(12)2.28%
Revenue beat(16)11
Avg Revenue beat(16)1.58%
PT rev (1m)-4.86%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.07%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.12
Fwd PE 14.89
P/S 1.83
P/FCF 19.49
P/OCF 14.53
P/B N/A
P/tB N/A
EV/EBITDA 11.79
EPS(TTM)5.72
EY6.61%
EPS(NY)5.81
Fwd EY6.71%
FCF(TTM)4.44
FCFY5.13%
OCF(TTM)5.95
OCFY6.88%
SpS47.24
BVpS-0.15
TBVpS-12.63
PEG (NY)N/A
PEG (5Y)14.92
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROCE 31.18%
ROIC 21.9%
ROICexc 22.99%
ROICexgc 49.37%
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
FCFM 9.39%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexgc growth 3Y25.21%
ROICexgc growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Debt/EBITDA 2.17
Cap/Depr 98.19%
Cap/Sales 3.2%
Interest Coverage 250
Cash Conversion 68.35%
Profit Quality 80.4%
Current Ratio 0.76
Quick Ratio 0.5
Altman-Z 3.11
F-Score6
WACC7.68%
ROIC/WACC2.85
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
EPS Next Y-22.5%
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%
EPS Next 5Y1.55%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%
Revenue Next Year-7.88%
Revenue Next 2Y-1.74%
Revenue Next 3Y-0.22%
Revenue Next 5Y1.2%
EBIT growth 1Y-13.41%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year5.87%
EBIT Next 3Y7.02%
EBIT Next 5Y6.3%
FCF growth 1Y-19.9%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y-14.7%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%

CLOROX COMPANY / CXX.DE FAQ

Can you provide the ChartMill fundamental rating for CLOROX COMPANY?

ChartMill assigns a fundamental rating of 4 / 10 to CXX.DE.


What is the valuation status of CLOROX COMPANY (CXX.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CLOROX COMPANY (CXX.DE). This can be considered as Fairly Valued.


How profitable is CLOROX COMPANY (CXX.DE) stock?

CLOROX COMPANY (CXX.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CXX stock?

The Price/Earnings (PE) ratio for CLOROX COMPANY (CXX.DE) is 15.12 and the Price/Book (PB) ratio is -563.53.


How sustainable is the dividend of CLOROX COMPANY (CXX.DE) stock?

The dividend rating of CLOROX COMPANY (CXX.DE) is 6 / 10 and the dividend payout ratio is 76.11%.